We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease.
- Authors
Uchida, Mona; Matsumiya, Yuki; Tsuboi, Masaya; Uchida, Kazuyuki; Nakagawa, Takayuki; Fujii, Wataru; Kobayashi, Tetsuya; Tsujimoto, Hajime; Ohmi, Aki; Tomiyasu, Hirotaka; Motegi, Tomoki; Maeda, Shingo; Momoi, Yasuyuki; Yonezawa, Tomohiro
- Abstract
Histiocytic sarcoma (HS) is a rare neoplasm of macrophages or dendritic cells with a poor prognosis in dogs. As the apoptosis inhibitor of macrophage (AIM) is characteristically expressed in canine macrophages, we hypothesised that AIM is involved in the development or progression of HS in dogs. In this study, AIM expression in the tumour region and serum AIM levels in dogs with HS was assessed. Additionally, the effects of AIM overexpression on HS cell viability were investigated using a HS cell line that was selected from five validated HS cell lines. Immunohistochemistry showed that AIM expression was observed in the cytoplasm of the HS cells. CD36, a candidate AIM receptor, was also observed on the cell membrane of HS cells. When the serum AIM level was detected in 36 dogs with HS and 10 healthy dogs via western blot analysis, the AIM levels in the HS dogs were significantly higher than those in the controls. AIM mRNA expression in the 5 HS cell lines varied but was higher than that in the other tumour‐derived lines. Among the five HS cell lines, DH82 originally had lower AIM and the highest CD36 expression. When AIM was overexpressed in DH82, therein cell growth speed and invasion, apoptosis inhibition and phagocytic activity were strongly upregulated. These data suggest that elevated intra‐tumour expression of AIM could induce the progression of HS cells in dogs. Moreover, elevated serum AIM levels in dogs with HS could serve as a biomarker of HS.
- Subjects
RETICULUM cell sarcoma; CELL migration inhibition; DOGS; APOPTOSIS inhibition; WESTERN immunoblotting; MACROPHAGES; CELL survival
- Publication
Veterinary & Comparative Oncology, 2023, Vol 21, Issue 3, p391
- ISSN
1476-5810
- Publication type
Article
- DOI
10.1111/vco.12897